BridgeBio Pharma stock price
브리지바이오 파머NASDAQ:BBIO · Nasdaq · HealthcareToday's signals · MACD bullish cross
Signal details →BridgeBio Pharma last closed at $67.25 (+0.51%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -18.9×. Its overall grade ranks 86 of 739 stocks in Healthcare.
About this company
BridgeBio Pharma last closed at $67.25 (+0.51%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 86/739
Valuation grade A+
Related stocks
- PfizerCompetitor
희귀질환·유전질환 치료제 영역에서 경쟁 가능성이 큰 글로벌 제약사
- NovartisCompetitor
희귀질환 및 유전자 기반 치료제 개발에서 경쟁하는 대형 제약사
- SanofiCompetitor
희귀질환·유전질환 치료제 시장에서 경쟁하는 글로벌 제약사
ETFs holding this stock
Franklin Genomic Advancements ETF
Details →About BridgeBio Pharma
- What technical signals does BridgeBio Pharma (BBIO) have?
- BridgeBio Pharma current technical signals: MACD bullish cross.
- Is BridgeBio Pharma a cup-and-handle pattern?
- No. BridgeBio Pharma has no valid Cup signal right now.
- What published figures are available for BridgeBio Pharma?
- Market cap: $12.96B. Trailing 12 months PER: -18.9×. Latest quarter PBR: -5.25×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about BridgeBio Pharma, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.